Tokyo Tape
Sign in
← Soiken Holdings

Half-year report · Q2

2385.TEDINET S100V7YR
Period2024-07-01 → 2024-12-31
Filed2025-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥5.2bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥2.8bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income−¥203m2024-07-01 → 2024-12-31Cons.Operating income
Operating income−¥455m2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income−¥198m2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥566m2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥449m2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax−¥212m2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥449m2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)−¥222m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥662m2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥488m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income−¥222m2024-07-01 → 2024-12-31Cons.Profit loss
Net income−¥489m2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥6.6bnat 2024-12-31Cons.Assets
Total assets¥6.9bnat 2024-06-30Cons.Assets
Total assets¥7.1bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥557mat 2024-12-31Cons.Liabilities
Total liabilities¥697mat 2024-06-30Cons.Liabilities
Net assets / equity¥6.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥6.2bnat 2024-06-30Cons.Net assets
Net assets / equity¥6.4bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.6bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥4.8bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥4.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.8bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow¥98m2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥881m2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥967m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥324m2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥14m2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥10m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥172,0002024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥261m2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥260m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-8.52024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.322023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.652023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio91.3%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.7%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 50
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥14m
Reconciling Itemsreconcilingrevenue external2024-07-01 → 2024-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥15m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥159m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥19m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31¥25m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥4m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31−¥132m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2024-07-01 → 2024-12-31¥183m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2024-07-01 → 2024-12-31¥173m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥11m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2024-07-01 → 2024-12-31¥3m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥39m
—segment totalrevenue2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue external2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue intersegment2024-07-01 → 2024-12-31¥15m
—segment totalsegment profit2024-07-01 → 2024-12-31−¥45m
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥10m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2023-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥11m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥156m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥72m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥270m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2023-12-31¥165m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥157m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥8m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2023-12-31−¥701,000
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥43m
—segment totalrevenue2023-07-01 → 2023-12-31¥2.9bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥2.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥11m
—segment totalsegment profit2023-07-01 → 2023-12-31−¥299m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Gross profitPrior1YTDDuration1378880000JPY
Gross profitCurrentYTDDuration1331192000JPY
Selling general and administrative expensesPrior1YTDDuration1833966000JPY
Selling general and administrative expensesCurrentYTDDuration1534235000JPY
Operating incomePrior1YTDDuration-455085000JPY
Operating incomeCurrentYTDDuration-203043000JPY
Interest income noiPrior1YTDDuration31000JPY
Interest income noiCurrentYTDDuration598000JPY
Compensation income for damage noiPrior1YTDDuration3719000JPY
Compensation income for damage noiCurrentYTDDuration1930000JPY
Other noiPrior1YTDDuration3010000JPY
Other noiCurrentYTDDuration2372000JPY
Non operating incomePrior1YTDDuration6760000JPY
Non operating incomeCurrentYTDDuration4902000JPY
Other noePrior1YTDDuration965000JPY
Other noeCurrentYTDDuration2000JPY
Non operating expensesPrior1YTDDuration965000JPY
Non operating expensesCurrentYTDDuration2000JPY
Ordinary incomePrior1YTDDuration-449290000JPY
Ordinary incomeCurrentYTDDuration-198143000JPY
Loss on closing of office elPrior1YTDDuration－JPY
Loss on closing of office elCurrentYTDDuration14300000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration134000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration134000JPY
Extraordinary lossCurrentYTDDuration14300000JPY
Income before income taxesPrior1YTDDuration-449425000JPY
Income before income taxesCurrentYTDDuration-212444000JPY
Income taxes currentPrior1YTDDuration3871000JPY
Income taxes currentCurrentYTDDuration4790000JPY
Income taxes deferredPrior1YTDDuration35235000JPY
Income taxes deferredCurrentYTDDuration5107000JPY
Income taxesPrior1YTDDuration39106000JPY
Income taxesCurrentYTDDuration9898000JPY
Profit lossPrior1YTDDuration-488531000JPY
Profit lossCurrentYTDDuration-222342000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-645000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-57000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-487886000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-222285000JPY
Profit lossPrior1YTDDuration-488531000JPY
Profit lossCurrentYTDDuration-222342000JPY
Comprehensive incomePrior1YTDDuration-488531000JPY
Comprehensive incomeCurrentYTDDuration-222342000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-487886000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-222285000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-645000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-57000JPY
Income before income taxesPrior1YTDDuration-449425000JPY
Income before income taxesCurrentYTDDuration-212444000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass